M. Abdel-Gawad, M. Zaghloul, S. Abd-Elsalam, M. Hashem, S. A. Lashen, A. Mahros, A. Mohammed, Amro M. Hassan, Ahmed Bekhit, W. Mohammed, M. Alboraie
{"title":"新冠肺炎后综合征临床表现:系统回顾。","authors":"M. Abdel-Gawad, M. Zaghloul, S. Abd-Elsalam, M. Hashem, S. A. Lashen, A. Mahros, A. Mohammed, Amro M. Hassan, Ahmed Bekhit, W. Mohammed, M. Alboraie","doi":"10.2174/1871523021666220328115818","DOIUrl":null,"url":null,"abstract":"BACKGROUND\nCoronavirus disease-2019 (COVID-19) is a global pandemic health problem which causes a wide spectrum of clinical manifestations and considerable mortality rates. Unfortunately, recovered patients who survive COVID-19 may continue to report wide varieties of clinical manifestations of multisystem affection such as fatigue, dyspnea, myalgia, anxiety, depression, acute myocardial infarction, peripheral and pulmonary embolisms.\n\n\nOBJECTIVE\nWe aimed to assess the prevalence of post-COVID-19 manifestations.\n\n\nMETHODS\nWe conducted a systematic review on post COVID-19 manifestations by searching Pubmed, Scopus, Web of Science (WOS), EBSCO, Wily, and World health organization (WHO) databases. Screening, selection, data extraction, data synthesis and quality assessment were done by two independent reviewers.\n\n\nRESULTS\nOf 1,371 references, 817 references remained after duplicates, reviews; case reports, commentaries, and any article containing non-original information were removed. According to eligibility criteria for this systematic review, 12 studies were included for qualitative synthesis. The overall prevalence of post-COVID-19 manifestations ranged from 35% to 90.5%. Fatigue, dyspnea, neuropsychological disorders, and pain were the most frequent post COVID-19 symptoms.\n\n\nCONCLUSIONS\nThis systematic review showed that 35% to 90.5% of recovered patients who survive COVID-19 continue to have wide varieties of clinical manifestations and fatigue, dyspnea, neuropsychological disorders, and pain were the most frequent post COVID-19 symptoms.","PeriodicalId":35423,"journal":{"name":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Post COVID-19 Syndrome Clinical Manifestations: A Systematic Review.\",\"authors\":\"M. Abdel-Gawad, M. Zaghloul, S. Abd-Elsalam, M. Hashem, S. A. Lashen, A. Mahros, A. Mohammed, Amro M. Hassan, Ahmed Bekhit, W. Mohammed, M. Alboraie\",\"doi\":\"10.2174/1871523021666220328115818\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND\\nCoronavirus disease-2019 (COVID-19) is a global pandemic health problem which causes a wide spectrum of clinical manifestations and considerable mortality rates. Unfortunately, recovered patients who survive COVID-19 may continue to report wide varieties of clinical manifestations of multisystem affection such as fatigue, dyspnea, myalgia, anxiety, depression, acute myocardial infarction, peripheral and pulmonary embolisms.\\n\\n\\nOBJECTIVE\\nWe aimed to assess the prevalence of post-COVID-19 manifestations.\\n\\n\\nMETHODS\\nWe conducted a systematic review on post COVID-19 manifestations by searching Pubmed, Scopus, Web of Science (WOS), EBSCO, Wily, and World health organization (WHO) databases. Screening, selection, data extraction, data synthesis and quality assessment were done by two independent reviewers.\\n\\n\\nRESULTS\\nOf 1,371 references, 817 references remained after duplicates, reviews; case reports, commentaries, and any article containing non-original information were removed. According to eligibility criteria for this systematic review, 12 studies were included for qualitative synthesis. The overall prevalence of post-COVID-19 manifestations ranged from 35% to 90.5%. Fatigue, dyspnea, neuropsychological disorders, and pain were the most frequent post COVID-19 symptoms.\\n\\n\\nCONCLUSIONS\\nThis systematic review showed that 35% to 90.5% of recovered patients who survive COVID-19 continue to have wide varieties of clinical manifestations and fatigue, dyspnea, neuropsychological disorders, and pain were the most frequent post COVID-19 symptoms.\",\"PeriodicalId\":35423,\"journal\":{\"name\":\"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-03-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1871523021666220328115818\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1871523021666220328115818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 9
摘要
背景冠状病毒病-2019 (COVID-19)是一种全球性的大流行卫生问题,可导致广泛的临床表现和相当高的死亡率。不幸的是,从COVID-19中幸存下来的康复患者可能会继续报告各种各样的多系统影响的临床表现,如疲劳、呼吸困难、肌痛、焦虑、抑郁、急性心肌梗死、外周栓塞和肺栓塞。目的了解新冠肺炎后表现的流行情况。方法通过检索Pubmed、Scopus、Web of Science (WOS)、EBSCO、Wily、World health organization (WHO)等数据库,对COVID-19术后临床表现进行系统评价。筛选、选择、数据提取、数据综合和质量评估由两名独立评审员完成。结果1371篇文献中,817篇文献经重复审稿后保留;病例报告、评论和任何包含非原创信息的文章均被删除。根据本系统评价的入选标准,纳入了12项研究进行定性综合。covid -19后表现的总体患病率为35%至90.5%。疲劳、呼吸困难、神经心理障碍和疼痛是最常见的COVID-19后症状。结论本系统评价显示,35% ~ 90.5%的新冠肺炎康复患者仍有多种临床表现,疲劳、呼吸困难、神经心理障碍和疼痛是最常见的新冠肺炎后症状。
Post COVID-19 Syndrome Clinical Manifestations: A Systematic Review.
BACKGROUND
Coronavirus disease-2019 (COVID-19) is a global pandemic health problem which causes a wide spectrum of clinical manifestations and considerable mortality rates. Unfortunately, recovered patients who survive COVID-19 may continue to report wide varieties of clinical manifestations of multisystem affection such as fatigue, dyspnea, myalgia, anxiety, depression, acute myocardial infarction, peripheral and pulmonary embolisms.
OBJECTIVE
We aimed to assess the prevalence of post-COVID-19 manifestations.
METHODS
We conducted a systematic review on post COVID-19 manifestations by searching Pubmed, Scopus, Web of Science (WOS), EBSCO, Wily, and World health organization (WHO) databases. Screening, selection, data extraction, data synthesis and quality assessment were done by two independent reviewers.
RESULTS
Of 1,371 references, 817 references remained after duplicates, reviews; case reports, commentaries, and any article containing non-original information were removed. According to eligibility criteria for this systematic review, 12 studies were included for qualitative synthesis. The overall prevalence of post-COVID-19 manifestations ranged from 35% to 90.5%. Fatigue, dyspnea, neuropsychological disorders, and pain were the most frequent post COVID-19 symptoms.
CONCLUSIONS
This systematic review showed that 35% to 90.5% of recovered patients who survive COVID-19 continue to have wide varieties of clinical manifestations and fatigue, dyspnea, neuropsychological disorders, and pain were the most frequent post COVID-19 symptoms.
期刊介绍:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new anti-inflammatory & anti-allergy agents. Publishing a series of timely in-depth reviews written by leaders in the field covering a range of current topics, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in the field.